Antimicrobial susceptibility and molecular epidemiology of beta-lactamase-producing, aminoglycoside-resistant isolates of Enterococcus faecalis
- PMID: 1929246
- PMCID: PMC284289
- DOI: 10.1128/AAC.35.6.1075
Antimicrobial susceptibility and molecular epidemiology of beta-lactamase-producing, aminoglycoside-resistant isolates of Enterococcus faecalis
Abstract
beta-Lactamase-producing (BL+), aminoglycoside-resistant (AR) Enterococcus faecalis is endemic in our hospital, having caused widespread colonization and infection. Suitable therapy for infections caused by these organisms has been problematic. We compared the antimicrobial and bactericidal activities, by broth macrodilution and time-kill methods, of several antibiotics, alone and in combination, against BL+, AR isolates of E. faecalis and determined the transmissibility of antibiotic resistance markers. Ampicillin-sulbactam, imipenem, daptomycin, and ciprofloxacin were the most active antibiotics with MICs for 90% of isolates tested of 2, 1, 2, and 1 microgram/ml, respectively, against inocula of 10(3) and 10(5) CFU/ml. Little inoculum effect was noted with imipenem, vancomycin, daptomycin, or ciprofloxacin, while the addition of sulbactam to ampicillin partially inhibited the effect of the increased inoculum. Penicillin-sulbactam and ampicillin-sulbactam combinations in a 2:1 ratio were most frequently bactericidal (greater than or equal to 3-log10-unit decrease in bacterial titers at 24 h for 13 of 20 isolates), followed by daptomycin (8 of 20 isolates) and ciprofloxacin (2 of 20 isolates). Bactericidal activity was not demonstrated for imipenem or teicoplanin. beta-Lactamase production and aminoglycoside resistance were associated with a 60- to 65-MDa plasmid which was easily transferred to a plasmid-free E. faecalis recipient. The 840-bp beta-lactamase gene probe hybridized to purified plasmid DNA from BL+ donor isolates of E. faecalis and transconjugants but not from BL- isolates. Ampicillin-sulbactam and daptomycin (an investigational antibiotic) seem to be reasonable choices for the empiric therapy of presumed enterococcal infections in hospitals in which BL+, AR E. faecalis strains are isolated. Their use should ideally be supported by tests for bactericidal activity.
Similar articles
-
Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.Antimicrob Agents Chemother. 1993 Jul;37(7):1447-51. doi: 10.1128/AAC.37.7.1447. Antimicrob Agents Chemother. 1993. PMID: 8363374 Free PMC article.
-
Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates.Antimicrob Agents Chemother. 2007 Jun;51(6):2043-7. doi: 10.1128/AAC.00131-07. Epub 2007 Apr 16. Antimicrob Agents Chemother. 2007. PMID: 17438057 Free PMC article.
-
Chemoprophylactic efficacy against experimental endocarditis caused by beta-lactamase-producing, aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity.Antimicrob Agents Chemother. 1990 Jun;34(6):1068-74. doi: 10.1128/AAC.34.6.1068. Antimicrob Agents Chemother. 1990. PMID: 2118323 Free PMC article.
-
Enterococcal Infection—Treatment and Antibiotic Resistance.2014 Feb 6. In: Gilmore MS, Clewell DB, Ike Y, Shankar N, editors. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection [Internet]. Boston: Massachusetts Eye and Ear Infirmary; 2014–. 2014 Feb 6. In: Gilmore MS, Clewell DB, Ike Y, Shankar N, editors. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection [Internet]. Boston: Massachusetts Eye and Ear Infirmary; 2014–. PMID: 24649502 Free Books & Documents. Review.
-
Enterococcus faecalis Endocarditis and Outpatient Treatment: A Systematic Review of Current Alternatives.Antibiotics (Basel). 2020 Sep 30;9(10):657. doi: 10.3390/antibiotics9100657. Antibiotics (Basel). 2020. PMID: 33007853 Free PMC article. Review.
Cited by
-
Beta-lactamase-producing enterococci.Antimicrob Agents Chemother. 1992 Nov;36(11):2355-9. doi: 10.1128/AAC.36.11.2355. Antimicrob Agents Chemother. 1992. PMID: 1489177 Free PMC article. Review. No abstract available.
-
Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states.J Clin Microbiol. 1993 Jun;31(6):1609-11. doi: 10.1128/jcm.31.6.1609-1611.1993. J Clin Microbiol. 1993. PMID: 8315004 Free PMC article.
-
Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.Drugs. 1994 May;47(5):823-54. doi: 10.2165/00003495-199447050-00008. Drugs. 1994. PMID: 7520860 Review.
-
Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.Antimicrob Agents Chemother. 1993 Jul;37(7):1447-51. doi: 10.1128/AAC.37.7.1447. Antimicrob Agents Chemother. 1993. PMID: 8363374 Free PMC article.
-
Emergence and nosocomial transmission of ampicillin-resistant enterococci.Antimicrob Agents Chemother. 1992 May;36(5):1032-9. doi: 10.1128/AAC.36.5.1032. Antimicrob Agents Chemother. 1992. PMID: 1510390 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials